Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment
Abstract Triple-negative breast cancer (TNBC) is associated with a high rate of early recurrence and distant metastasis, frequent development of therapeutic resistance, and a poor prognosis. There is a lack of targeted therapies for this aggressive subtype of breast cancer. Identifying novel effecti...
Guardado en:
Autores principales: | Bowen Gao, Jiongyu Chen, Bingchen Han, Xinfeng Zhang, Jijun Hao, Armando E. Giuliano, Yukun Cui, Xiaojiang Cui |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0c576c9d1a8f4aa88792c764c17985e6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Triptonide is a reversible non-hormonal male contraceptive agent in mice and non-human primates
por: Zongliang Chang, et al.
Publicado: (2021) -
Novel therapeutic strategies for patients with metastatic triple-negative breast cancer
por: Inna P. Ganshina, et al.
Publicado: (2021) -
TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer.
por: Virginie Maire, et al.
Publicado: (2013) -
Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes
por: Brian D. Lehmann, et al.
Publicado: (2021) -
Current Status of Breast Organoid Models
por: Srivarshini Cherukupalli Mohan, et al.
Publicado: (2021)